Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials (Q27022613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Nanne Kleefstra

Nanne

Kleefstra

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Gijs W D Landman

Gijs W D

Landman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Kornelis J J van Hateren

Kornelis J J

van Hateren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Peter R van Dijk

Peter R

van Dijk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Klaas H Groenier

Klaas H

Groenier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Rijk O B Gans

Rijk O B

Gans

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sebastiaan T Houweling

Sebastiaan T

Houweling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Henk J G Bilo

Henk J G

Bilo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

1 reference

2014

1 reference

12 February 2014

6 references

13 March 2019

14 March 2019

24 March 2019

12 November 2019

4 February 2021

24 January 2024

8 references

13 March 2019

14 March 2019

24 March 2019

12 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

4 February 2021

24 January 2024

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

e82880

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

5 June 2020

6 references

13 March 2019

14 March 2019

24 March 2019

12 November 2019

4 February 2021

on focus list of Wikimedia project

24 January 2024

copyrighted

0 references

ScienceSource

0 references

cites work

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Variations in tissue selectivity amongst insulin secretagogues: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Increased fibrinolytic potential induced by gliclazide in types I and II diabetic patients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922704

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

31 May 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Is this clinical trial fully registered?--A statement from the International Committee of Medical Journal Editors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Effects of combination of insulin and acarbose compared with insulin and gliclazide in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Efficacy and safety comparison between the DPP-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-naïve patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082880

Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas

21 January 2018

1 reference

12 December 2020

Lack of effect of gliclazide on early diabetic nephropathy and retinopathy: a two-year controlled study

1 reference

12 December 2020

Glibenclamide vs gliclazide in type 2 diabetes of the elderly

1 reference

12 December 2020

Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0082880

Identifiers

DOI

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

ADS bibcode

2014PLoSO...982880L

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

PubMed publication ID

24533045

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533045%20AND%20SRC:MED&resulttype=core&format=json